Bicarbonate Patents (Class 424/717)
-
Patent number: 7476660Abstract: The present invention relates to a composition for organ preservation, comprising an inulin type fructan as an active ingredient. The composition for organ preservation can suppress the hypofunction of an organ and damage to a histological structure and can improve the state of preservation of the organ in the course of organ transplantation and the like.Type: GrantFiled: March 28, 2003Date of Patent: January 13, 2009Assignee: Meiji Seika Kaisha, Ltd.Inventors: Yoshihiko Masaki, Kazunari Yoshida, Tadao Endo, Hirofumi Nakamura, Yasuhito Tashiro
-
Publication number: 20080317855Abstract: An ingestible particulate composition comprises: a. an alginate and/or alginic acid; b. a bicarbonate and/or carbonate; c. an organic acid; and d. an agglomerant, being a compound, such as a low molecular weight polyol, which allows the particulate composition to flow yet which substantially does not release fine particulates into the air. Resulting particulate compositions have excellent flow characteristics, dust suppression, organoleptic properties and stability. They are highly suitable for administration direction into a patient's mouth, and ingested to alleviate oesophageal and gastric conditions.Type: ApplicationFiled: July 27, 2006Publication date: December 25, 2008Applicant: RECKITT BENCKISER HEALTCARE (UK) LIMITED,Inventors: Ian Gordon Jolliffe, Charles Trafford, Olav Gaserod
-
Publication number: 20080292731Abstract: Methods for providing post-operative pain control or relief to a patient are disclosed. Methods include, for example, administering bicarbonate to an area of a patient during a surgical or dental procedure, near completion of a surgical or dental procedure or immediately following a surgical or dental procedure, in an area previously administered or containing a regional or local anesthetic in an amount sufficient to provide the patient with pain control or relief for a period of time after the surgical or dental procedure.Type: ApplicationFiled: May 21, 2008Publication date: November 27, 2008Inventor: GLENN ABRAHMSOHN
-
Publication number: 20080279965Abstract: Methods and compositions that inhibit acid sensing ion channels are provided for the prevention and treatment of brain injury, including injury caused by stroke or seizure. The methods and compositions of the invention are additionally effective for the reduction of acidosis in the brain.Type: ApplicationFiled: November 20, 2007Publication date: November 13, 2008Inventors: Roger P. SIMON, Zhi-Gang Xiong
-
Patent number: 7445801Abstract: Stable single bicarbonate-based solutions are provided. The bicarbonate-based single solution of the present invention includes at least calcium and bicarbonate and is stored or packaged in a sterile manner within a container with a gas barrier. The single solutions of the present invention can remain stable for three months or more. In this regard, the stable and single bicarbonate-based solutions of the present invention can be readily and effectively used during medical therapy, such as dialysis therapy.Type: GrantFiled: June 7, 2002Date of Patent: November 4, 2008Assignees: Baxter International Inc., Baxter Healthcare S.AInventors: Dirk Faict, Annick Duponchelle, Michel Taminne, Patrick Balteau, Francesco Peluso
-
Publication number: 20080213327Abstract: Method using a parasiticidal powder typically comprising from 1 to 15% by weight of silica and from 85 to 99% of alkali metal bicarbonate.Type: ApplicationFiled: March 16, 2006Publication date: September 4, 2008Applicant: SOLVAY (SOCIETE ANONYME)Inventors: Jean-Philippe Pascal, Nicolas Palangie
-
Patent number: 7413753Abstract: A composition for delivery of osteogenic proteins is disclosed. The composition comprises an osteogenic protein, a calcium phosphate material as a carrier, and an effective amount of an effervescent agent. Methods of making the compositions and methods of using the osteogenic compositions to treat osteoporotic and/or osteopenic bone are also disclosed.Type: GrantFiled: May 31, 2002Date of Patent: August 19, 2008Assignees: Wyeth, Etex CorporationInventors: Rebecca H. Li, Howard Seeherman
-
Publication number: 20080171069Abstract: Parasiticidal aqueous suspension Parasiticidal aqueous suspension typically comprising from 1 to 15% by weight of silica and from 30 to 45% of alkali metal bicarbonate, and method for controlling the development of parasites on animals reared in buildings, according to which the animal's environment in the building is brought into contact with this aqueous suspension.Type: ApplicationFiled: March 15, 2006Publication date: July 17, 2008Applicant: SOLVAY (SOCIETE ANONYME)Inventors: Jean-Philippe Pascal, Nicolas Palangie
-
Patent number: 7368121Abstract: A process for eradicating moss and liverwort which includes applying sodium percarbonate; and irrigating the moss. In some cases the process includes applying lime to control the pH of the moss and thereby constrain development of additional moss and said sodium percarbonate is a solid material.Type: GrantFiled: October 5, 2005Date of Patent: May 6, 2008Inventor: Robert A Larose
-
Patent number: 7347994Abstract: The invention is a method for attracting mosquitoes by producing a volatilized acid by combining an acid precursor with water to produce the humidified vapor acid attractant, preferably hydrogen chloride. The humidified volatilized acid can be further combined with carbon dioxide, or carbon dioxide can be simultaneously produced to attract mosquitoes. The acid precursor can be a hydrate of ferric chloride, such as ferric chloride hexahydrate. The acid precursor can be impregnated in a carrier, and can be combined with water through exposure to water vapor in the atmosphere, the intentional addition of water, or water produced by a chemical reaction.Type: GrantFiled: September 12, 2003Date of Patent: March 25, 2008Assignee: ICA Trinova, LLCInventors: Joel Tenney, Tom Isaac, William Ernst
-
Patent number: 7345029Abstract: The present invention relates to a solution for peritoneal dialysis, consisting of at least two single solutions which are combined after a heat sterilization and are administered to a patient, the first single solution containing an osmotic and the second single solution containing a buffer, and one of these single solutions or another single solution containing electrolyte salts. The avoidance of a glucose-like degradation as well as hydrolysis during sterilization and storage while maintaining a neutral mixture pH is achieved according to the invention by the osmotic comprising a glucose polymer and/or glucose polymer derivative, and the pH of the first single solution being between 3.5 and 5.0. The present invention further relates to a twin-chambered pouch consisting of a plastic pouch with at least one first chamber and a second chamber, the first single solution being included in the first chamber and the second single solution being included in the second chamber.Type: GrantFiled: April 18, 2003Date of Patent: March 18, 2008Assignee: Fresenius Medical Care Deutschland GmbHInventor: Thomas Zimmeck
-
Patent number: 7323452Abstract: A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as catalysts or “pseudo” enzymes for the oxidation. These additives include multivalent transition metal ions, as well as complexes thereof, and NAD+ which enhance the oxidation reaction. The method described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.Type: GrantFiled: December 20, 2004Date of Patent: January 29, 2008Assignee: Wardan, L.L.C.Inventors: Ward B. Bowen, Jr., Daniel S. Daniel
-
Patent number: 7309502Abstract: The present invention relates to a pharmaceutical composition and the method for the preparation thereof. The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride, calcium gluconate, and the like, and 3˜18% (w/v) of one or more substances selected from hydroxyethylstarch, dextran, carboxymethylstarch, polyvinyl-pyrrolidone, gelatin derivatives, and the like as well as the remainder of conventional injections, as long as sodium chloride is not less than 1.5% (w/v). The pharmaceutical composition of the present invention is used to treat and save the wounded and patients, as well as to treat shock, its advantages include safe and convention use, rapid and good curative effect, long time maintenance, extensive uses and the like.Type: GrantFiled: August 5, 2005Date of Patent: December 18, 2007Inventor: Chaoying Zhao
-
Publication number: 20070281015Abstract: An anti-acid pharmaceutical composition for the rapid and prolonged neutralization of gastric acidity with mucosa-protecting activity in powder form to prepare, by dispersion in water, a pharmaceutical solution or suspension for oral use characterized in that the composition includes sodium alginate; an anti-acid soluble agent or a combination of anti-acids; an inhibitor of proton pump; diluent and sweetening agents, wherein a) at least 30% of sodium alginate present in the formulation along with the total of the inhibitor of proton pump are homogeneously distributed over the surface of the total soluble anti-acid agent or of the combination of anti-acids of the composition; and b) the rest, about 70%, of sodium alginate present in the formulation contains a percentage of humidity of less than 2%.Type: ApplicationFiled: June 5, 2007Publication date: December 6, 2007Inventor: Mario Atilio Los
-
Patent number: 7303755Abstract: The use of certain salts and aminoacids as stabilizer of the antibiotic Fosfomycin Tromethamol and pharmaceutical compositions containing them, is described.Type: GrantFiled: July 10, 2003Date of Patent: December 4, 2007Assignee: Zambon S.p.A.Inventors: Luca Rampoldi, Luca Pirrone, Sarah Faccin, Alessandro Grassano, Giovanni Gurrieri
-
Patent number: 7300674Abstract: The present invention relates to a sterile calcium-free low bicarbonate dialysis concentrate composition for use in conjunction with regional citrate anti-coagulation in the context of either dialysis or hemofiltration. Methods of use of the sterile calcium free low bicarbonate dialysis concentrate compositions are also disclosed. The low bicarbonate concentrate takes into account the fact that citrate is hepatically metabolized into bicarbonate, thus minimizing metabolic complications.Type: GrantFiled: December 19, 2001Date of Patent: November 27, 2007Inventor: Sheldon Tobe
-
Patent number: 7255883Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-?. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-? in a living organism.Type: GrantFiled: June 20, 2001Date of Patent: August 14, 2007Assignee: Healagenics, Inc.Inventors: Ki Chang Keum, Naechoon Yoo, Won-min Yoo
-
Patent number: 7205000Abstract: A slurry comprising (a) sodium bicarbonate, (b) sodium chloride, and (c) water, in a weight ratio of (a)/(b) of about 2.5:1 to about 3.5:1, wherein upon further dilution of said slurry with additional water, the amount of sodium bicarbonate and sodium chloride which dissolves into said additional water is in the same ratio as said of (a)/(b) in said slurry before said additional dilution.Type: GrantFiled: April 4, 2002Date of Patent: April 17, 2007Assignee: Church & Dwight Co., Inc.Inventor: Mark D. Einziger
-
Patent number: 7198779Abstract: New liquid compositions are described for the relief of the xerostomia and the treatment of associated disorders, in which the compositions contain: a) saline saliva substitute agents selected from the group consisting of sodium chloride, potassium chloride, sodium bicarbonate, monobasic potassium phosphate, and dibasic phosphate potassium; b) saliva production stimulation agents selected from the group consisting of citric acid or its alkali metal salts and malic acid or its alkali metal salts; c) oral antiseptics selected from the group consisting of triclosan, chlorhexidine and its salts, benzalkonium and its salts, and cetylpyridinium chloride; d) anticariogenic agents selected from the group consisting of fluoride sodium, sodium monofluorophosphate, and xylitol; and e) oral mucosa protective agents selected from the group consisting of vitamin E acetate, panthenol, dipotassium glycyrrhizinate and extracts of aloe vera.Type: GrantFiled: September 19, 2002Date of Patent: April 3, 2007Assignee: Lacer S.A.Inventors: Ana Rifa Piñol, Montserrat Mata Moliner
-
Patent number: 7122210Abstract: Bicarbonate containing solutions for use during medical treatment are provided. The bicarbonate containing solution of the present invention includes at least two separate components including a bicarbonate concentrate and an electrolyte concentrate which can be readily and sterilely mixed to form a ready-to-use formulation for patient administration, particularly as applied to the treatment of acute renal failure associated with critically ill patients in an intensive care setting.Type: GrantFiled: January 11, 2002Date of Patent: October 17, 2006Assignees: Baxter International Inc., Baxter Healthcare S.A.Inventors: Paola Elisabettini, Jean-Paul Menneguerre, Jerome Colas, Christian Renaux, Jose Divino, Dirk Faict, Isabelle Wilmet
-
Patent number: 7063865Abstract: A composition that will substantially reduce the deleterious effects of alcohol on the body and substantially reduce the side effects associated with hangovers (i.e. headaches, dizziness, nausea, dry mouth, etc) when taken as recommended. The composition includes an effective amount of (I)-glycine, (I)-glutathione, thiamine, magnesium, selenium, molybdenum. Other vitamins, mineral compounds, flavoring, coloring, and solubility agents may also be added.Type: GrantFiled: May 10, 2002Date of Patent: June 20, 2006Inventors: Jeremy Park Jones, Peter Kevin Dobler
-
Patent number: 7029690Abstract: Disclosed are articles and oral compositions which enable positioning material(s) which absorb oral fluids into controlled, direct contact with at least one dental arch, or portion thereof, of a subject at the location where teeth emerge from dental arch gum tissue, in a manner conducive to increasing crevicular fluid flow while maintaining a relatively dry application field for a therapeutic and/or cosmetic result effecting period of time. The method is applicable to introduction of gingivally absorbed substances and to treatment of, for instance, periodontal gum disease wherein bacteria is swept along in the crevicular fluid and lysed.Type: GrantFiled: November 4, 2002Date of Patent: April 18, 2006Assignee: Clinically Clean Inc.Inventor: Janet M. Wehrli
-
Patent number: 7029704Abstract: The anti-itch solution is a solution of hydrogen peroxide, sodium bicarbonate and apple cider vinegar applied to feet to prevent a common fungal infection of feet known as “athlete's foot”.Type: GrantFiled: December 29, 2003Date of Patent: April 18, 2006Inventor: Clifford E. Woods, Jr.
-
Patent number: 7029705Abstract: A method is disclosed of practicing nasal hygiene comprising the steps of applying to a person's nostril a non-irritating hygienic composition consisting essentially of a product of compounding under homogenizing conditions water, 0.01% to 5% by weight, as chlorine dioxide, of a source of chlorine dioxide; 0.01% to 3% by weight of at least one olfactory stimulant, 0 to 5% by weight of at least one fixative compound less volatile than the olfactory stimulant 0.1 to 2.5% by weight of at least one inorganic salt selected from the group consisting of alkali metal chloride, alkali metal bicarbonate, and alkali metal chlorate; and 0.0002 to 0.006% (as aluminum) by weight of at least one water soluble aluminum compound, provided that the total concentration of inorganic salt is in the range from 0.6% by weight to 2.5% by weight, holding the composition within the nostril for a hygienic holding period, and discharging the composition from the treated nostril.Type: GrantFiled: July 30, 2003Date of Patent: April 18, 2006Inventor: Allan H. Fuhr
-
Patent number: 7011855Abstract: A peritoneal dialysis solution that is biochemically balanced to correct metabolic acidosis associated with chronic renal failure in a more physiological manner. The peritoneal dialysis solution has a physiological pH, e.g., pH of 7.0 to 7.4, and contains bicarbonate at a concentration that is found in normal blood. Additionally, the solution contains carbon dioxide at a partial pressure that is similar to partial pressure of carbon dioxide found in normal blood. The peritoneal dialysis solution also contains a weak acid with a pKa of less than 5.0.Type: GrantFiled: September 17, 2001Date of Patent: March 14, 2006Assignee: Baxter International Inc.Inventors: Leo Martis, Lee W. Henderson
-
Patent number: 6994873Abstract: This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts, and to the preparation process of said formulations.Type: GrantFiled: February 4, 2002Date of Patent: February 7, 2006Assignee: Valpharma S.A.Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
-
Patent number: 6986905Abstract: The present invention relates to a pharmaceutical composition and the method for the preparation thereof, The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium chloride, sodium bicarbonate, potassium chloride, magnesium sulfate, calcium chloride, calcium gluconate, and the like, and 3˜18% (w/v) of one or more substances selected from hydroxyethylstarch, dextran, carboxymethylstarch, polyvinyl-pyrrolidone, gelatin derivatives, and the like as well as the remainder of conventional injections, as long as sodium chloride is not less than 1.5% (w/v). The pharmaceutical composition of the present invention is used to treat and save the wounded and patients, as well as to treat shock, its advantages include safe and convenient use, rapid and good curative effect, long time maintenance, extensive uses and the like.Type: GrantFiled: November 15, 2000Date of Patent: January 17, 2006Inventor: Chaoying Zhao
-
Patent number: 6974595Abstract: New pharmaceutical compositions for oral use containing Diclofenac together with alkali metal bicarbonates in amounts of from 20 to 80 by weight with respect to Diclofenac are described. These compositions are entirely palatable and free from any unpleasant taste or other side effects; in particular, these formulations permit to obtain in human patients higher Cmax of the active principle and shorter Tmax together with a lower coefficient of variation.Type: GrantFiled: March 14, 2000Date of Patent: December 13, 2005Assignee: ProEthic Pharmaceuticals, Inc.Inventors: Alberto Reiner, Giorgio Reiner
-
Patent number: 6974590Abstract: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.Type: GrantFiled: February 20, 2002Date of Patent: December 13, 2005Assignee: Cima Labs Inc.Inventors: Sathasivan Indiran Pather, Rajendra K. Khankari, Jonathan D. Eichman, Joseph R. Robinson, John Hontz
-
Patent number: 6896908Abstract: This invention relates to a leach-resistant borate preservative for lignocellulosic-based products, providing resistance against insect and fungal attack for use in exterior and ground contact applications. The preservative compositions of this invention may be provided as a high strength liquid concentrate, suitable for transportation, storage and easy on-site dilution, or as a ready-to-use treatment solution. These wood preservative compositions include a borate preservative component and a co-biocidal metal fixative such as copper or zinc. The preservative compositions also contain volatile organic acid, free ammonia and ammonium salts to aid dissolution. Methods for the application of these preservative compositions to wood are also provided.Type: GrantFiled: November 14, 2001Date of Patent: May 24, 2005Assignee: U.S. Borax Inc.Inventors: Jeffrey D. Lloyd, Jennifer L. Fogel
-
Patent number: 6884441Abstract: In contrast to the prior art, the essential components of dialyzing liquids are not provided as a dry concentrate or as a genuine solution at the place of dialysis, but as a suspension of undissolved or incompletely dissolved substances, preferably sodium chloride, optionally sodium acetate, in a solution of the remaining components. The suspension is prepared, stored, transported and used in a form designated as an acid cartridge or acetate cartridge, respectively. At the place of dialysis a liquid dialysis concentrate is prepared from the suspension by means of an apparatus, which is here suggested, and can be processed into dialyzing liquid with the existing dosing and safety systems of commercially available dialyzers. The prestage of a dialysis concentrate, which is described in this invention as a suspension, constitutes the supply form with the highest substance density for the components of acid and acetate-containing dialyzing liquids.Type: GrantFiled: August 30, 2002Date of Patent: April 26, 2005Assignee: Haas Medizintechnik GmbHInventors: Manfred Pippert, Uwe Hildmann, Hans-Gunther Eigendorf
-
Patent number: 6872408Abstract: The present invention provides a method for treating psychiatric disorders such as mania or depression in a patients, in particular, patients with a bipolar disorder, by providing substantially isotopically pure heavy water substantially free of protons, isotopically pure hydrogen-containing water substantially free of deuterium, isotopically pure carbonate compounds substantially free of deuterium, isotopically pure carbonate compounds substantially free of protons, isotopically pure phosphate compounds substantially free of deuterium, isotopically pure phosphate compounds substantially free of protons, or mixtures thereof to the patient. In particular, the present invention provides a method for treating manic symptoms in a patient and mania or depression in patients with a bipolar disorder.Type: GrantFiled: September 6, 2002Date of Patent: March 29, 2005Inventor: Rupert C. Bell
-
Patent number: 6841172Abstract: The invention relates to methods and compositions for delivering iron to an iron-deficient patient, more particularly, to methods whereby an iron complex comprising divalent or trivalent ionic iron complexed with one or more low molecular weight anions is administered to a patient by transfer from dialysate. A complex selected according to the invention is non-polymeric; soluble in an aqueous medium; chemically stable, thereby preventing the dissociation of iron ions from the anions under conditions according to the invention; and can be well absorbed into blood and the living body. Also provided are dialysate compositions including therein an iron complex selected according to the invention, and dialysate concentrates which may be diluted to yield an inventive dialysate composition.Type: GrantFiled: August 28, 1998Date of Patent: January 11, 2005Assignee: HemoCleanse, Inc.Inventor: Stephen R. Ash
-
Patent number: 6833362Abstract: A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or “pseudo” enzymes for the oxidation. Additives include the oxidant Nicotinamide Adenine Dinucleotide and a variety of other additives such as transition metal ions and complexes thereof which favor the oxidation reaction. The compositions described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.Type: GrantFiled: June 7, 2001Date of Patent: December 21, 2004Inventors: Ward Beryl Bowen, Jr., Daniel Salman Daniel
-
Publication number: 20040253324Abstract: A product and method for treating dehydration in neonatal calves. The product is administered to dehydrated calves during treatment, to the exclusion of milk replacers or electrolytes.Type: ApplicationFiled: November 6, 2003Publication date: December 16, 2004Applicant: NORTH AMERICAN NUTRITION COMPANIES, INC.Inventor: T. Mark Hill
-
Publication number: 20040209919Abstract: The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula 1Type: ApplicationFiled: April 28, 2004Publication date: October 21, 2004Applicant: TAKEDA CHEMICAL INDUSTRIES, LTD.Inventors: Tadashi Makino, Tetsuro Tabata, Shin-Ichiro Hirai
-
Publication number: 20040191296Abstract: A method for adjusting the acidity levels of ordinary food ingested by humans comprises adding to food products potassium bicarbonate in a manner which allows the potassium bicarbonate to be dissolved in the foodstuff and to alter its acidity such that when it is ingested by the human body, the human body is able to maintain in vivo acidity levels that are below those which would have been obtained if the potassium bicarbonate would not have been pre-dissolved in the foodstuff.Type: ApplicationFiled: June 30, 2003Publication date: September 30, 2004Inventor: Joshua L. Sternberg
-
Publication number: 20040175437Abstract: An aqueous neutral to mildly alkaline metal bicarbonate solution is disclosed. The solution comprises metal bicarbonate dissolved in the solution, the metal bicarbonate comprising bicarbonate anions and metal cations. In addition there is a pH adjusting agent in the solution in an amount whereby the solution is at a neutral to mildly alkaline pH. Also disclosed is a process of preparing an aqueous neutral to mildly alkaline metal bicarbonate solution comprising bicarbonate anions and metal cations. The process comprises reacting a compound selected from the group consisting of metal carbonate, metal carbonate hydroxide, metal oxide, metal hydroxide and any mixture thereof with an effective concentration of a p ] [ adjusting agent to produce the aqueous neutral to mildly alkaline metal bicarbonate solution, wherein the pH adjusting agent is present in an amount whereby the solution is at a neutral to mildly alkaline pH.Type: ApplicationFiled: March 12, 2004Publication date: September 9, 2004Inventor: Russell John Beckett
-
Publication number: 20040170681Abstract: A dosage form such as a swallow tablet or a capsule formulation is described comprising paracetamol, low levels of sodium bicarbonate or potassium bicarbonate or mixtures thereof, and at least one pharmaceutically acceptable excipient.Type: ApplicationFiled: December 3, 2003Publication date: September 2, 2004Inventor: Timothy James Grattan
-
Patent number: 6780882Abstract: There is provided a solid pharmaceutical composition having active ingredients that include at least one non-enteric coated proton pump inhibitor and at least one buffering agent. The proton pump inhibitor, for example, omeprazole, lansoprazole, rabeprazole, esomeprazole, pantoprazole, pariprazole, and leminoprazole, or an enantiomer, isomer, derivative, free base, or salt thereof, is present in an amount of approximately 5 mg to approximately 300 mg; and the buffering agent is present in an amount of approximately 0.1 mEq to approximately 2.5 mEq per mg of proton pump inhibitor. The dosage form can be non-enteric coated and can be in the form of a suspension tablet, a chewable tablet, an effervescent powder, or an effervescent tablet. Also provided is a method for treating an acid-related gastrointestinal disorder in a subject in need thereof by administering to the subject a solid pharmaceutical composition of the present invention.Type: GrantFiled: September 30, 2002Date of Patent: August 24, 2004Assignee: The Curators of the University of MissouriInventor: Jeffrey O. Phillips
-
Patent number: 6770306Abstract: The present invention relates to a pharmaceutical composition for reducing vaginal acidity, treating abnormal enhancement of vaginal acidity, and high acidity vaginitis associated with abnormal enhancement of vaginal acidity, especially for the treatment of fungal vaginitis, comprising of one or more ingredients defined as follows: amino acids, physiologically acceptable salts of amino acids, oligopeptides and polypeptides. Also, the present invention relates to the use of the said amino acids, physiologically acceptable salts of amino acids, oligopeptides and polypeptides, as active ingredients or auxiliaries in preparing drugs for reducing vaginal acidity, the treatment of abnormal enhancement of vaginal acidity, and high acidity vaginitis especially to their use in preparing drugs for the treatment of fungal vaginitis and the use thereof as nutrients for vaginal mucous membranes in preparing drugs that are locally applied in the vagina.Type: GrantFiled: January 3, 2001Date of Patent: August 3, 2004Inventor: Zhongming Zeng
-
Publication number: 20040126436Abstract: Compositions for assisting in the removal of human cerumen are disclosed. The compositions may include bicarbonate and an otologically acceptable vehicle; a cerumenolytically acceptable enzyme and an otologically acceptable vehicle; or bicarbonate, a cerumenolytically acceptable enzyme, and an otologically acceptable vehicle.Type: ApplicationFiled: November 10, 2003Publication date: July 1, 2004Inventors: Gerald D. Cagle, Geoffrey R. Owen, Nuria Jimenez Ridruejo, G. Michael Wall
-
Publication number: 20040121026Abstract: A non-toxic formulation to selectively control and kill undesirable epiphytic weeds by applying active ingredients in an effective amount of sodium bicarbonate, potassium salts of fatty acids, sulfur, sesame oil and water.Type: ApplicationFiled: December 23, 2002Publication date: June 24, 2004Inventor: Jeffrey Lee Kaplan
-
Patent number: 6746681Abstract: A toothpaste preparation provides baking soda, Vitamins A, C, D, and E, Pyridoxine HCl, Thiamine HCl, within a gel base, and given a pet attractive odor by the addition of small quantities of liquid flavoring. The clear gel limits the unsightly appearance of the gel should it become adhered to the pet's fur.Type: GrantFiled: December 20, 2002Date of Patent: June 8, 2004Assignee: Preventive Dental Specialties, Inc.Inventor: David T. Carroll
-
Patent number: 6743191Abstract: The invention relates to a substitution infusion fluid for hemofiltration of a specific composition. The use of said substitution infusion fluid significantly reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration. The invention also relates to process for pure hemofiltration of blood wherein said substitution infusion fluid is used. The invention also relates to a matching citrate anticoagulation fluid of a specific composition. The invention also relates to a process for pure hemofiltration of blood wherein said substitution infusion fluid is used in combination with said citrate anticoagulation fluid. The use of said substitution infusion fluid in combination with said citrate anticoagulation fluid significantly further reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration.Type: GrantFiled: October 23, 2001Date of Patent: June 1, 2004Assignee: Edwards Lifesciences AGInventor: Pe Chou Chang
-
Publication number: 20040101490Abstract: An oral composition or dentifrice containing sodium bicarbonate, wherein the salty taste ordinarily imparted by the sodium bicarbonate is completely or partially masked by the combination of effective amounts of an ion-channel competitor, an initial sweetener and a delayed sweetener. The oral composition or dentifrice preferably contains sodium citrate as the ion-channel competitor, saccharin as the initial sweetener, and mono-ammonium glycyrrhizinate as the delayed sweetener.Type: ApplicationFiled: November 22, 2002Publication date: May 27, 2004Applicant: NOVILLE INC.Inventor: Roger E. Stier
-
Publication number: 20040086578Abstract: Artificial plasma-like solutions and methods for their use are provided. The subject solutions include: electrolytes and an oncotic agent. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute.Type: ApplicationFiled: October 10, 2003Publication date: May 6, 2004Inventors: Paul E. Segall, Hal Sternberg, Harold D. Waitz, Judith M. Segall
-
Publication number: 20040071793Abstract: An improved oral rehydration solution comprising standard formulae of sugars, mineral salts and bicarbonates in combination with Croton species materials with or without the inclusion of material from the Uncaria species. The botanical components are concentrated biologically active materials and thus enhance therapeutic benefit. The Croton component functions as an effective non-paralytic agent in managing diarrhea that is superior to loperamide resulting in a lower stool output. The functionality of the Uncaria species is as an effective anti-inflammatory agent via NF-□B activation inhibition and protecting gastrointestinal epithelial cells from oxidant-induced death.Type: ApplicationFiled: October 3, 2003Publication date: April 15, 2004Inventor: Paul J. Bobrowski
-
Publication number: 20040052757Abstract: A novel facial peel composition is disclosed for treatment of acne, acne scarring and large skin pores. The facial peel composition is non-surgical, non-laser and contains no acids that can burn or disfigure skin. Its ingredients are all natural and avoids the use of hard non-dissolving abrasives such as aluminum oxide, polymers, plastic or silica. The ingredients include sodium bicarbonate crystals, cornstarch, aloe and water. The sodium bicarbonate crystals are an antibacterial agent that remove acne causing, bacteria laden skin oil. The cornstarch aids in drawing bacteria away from the skin and into suspension for rinsing. The aloe reduces soreness and inflammation to the skin and is a known natural healing agent. A method of preparation of the composition is also disclosed.Type: ApplicationFiled: September 17, 2002Publication date: March 18, 2004Inventor: Gerard J. LeCompte
-
Patent number: 6699885Abstract: Disclosed herein are methods, kits, combinations, and compositions for treating gastric acid disorders employing pharmaceutical compositions comprising a proton pump inhibiting agent (PPI) and a buffering agent in a pharmaceutically acceptable carrier.Type: GrantFiled: January 19, 2002Date of Patent: March 2, 2004Assignee: The Curators of the University of MissouriInventor: Jeffrey O. Phillips